Genome-based therapeutic interventions for β-type hemoglobinopathies

For decades, various strategies have been proposed to solve the enigma of hemoglobinopathies, especially severe cases. However, most of them seem to be lagging in terms of effectiveness and safety. So far, the most prevalent and promising treatment options for patients with β-types hemoglobinopathie...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamperis, Kariofyllis, Tsoumpeli, Maria T., Kounelis, Fotios, Koromina, Maria, Mitropoulou, Christina, Moutinho, Catia, Patrinos, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178887/
https://www.ncbi.nlm.nih.gov/pubmed/34090531
http://dx.doi.org/10.1186/s40246-021-00329-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178887/
https://www.ncbi.nlm.nih.gov/pubmed/34090531
http://dx.doi.org/10.1186/s40246-021-00329-0

Ejemplares similares